Also known as: WCG
WCG is a clinical research solutions company that provides independent ethical review, study planning, site enablement, and data and insights services. Its mission is to accelerate and improve the clinical research journey for sponsors, CROs, sites, and participants.
Analysts project AI in clinical trials will represent an $8 billion business segment by 2030, generating up to $110 billion per year in value to pharma. Multiple companies unveiled AI-powered platforms at SCOPE 2026 in Orlando.
Artificial intelligence emerged as the dominant topic in clinical research during 2025, with applications spanning operational efficiency, drug discovery, and patient recruitment, though no AI-discovered drug has yet achieved FDA marketing approval.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06509204 |
Real-world Evaluation of JBA GlucoTrojan With Reducose® on Glycemic Response |
COMPLETED | NA |
